Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 57

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 57
---
; |

| ● | 2,127,070 shares of common stock issuable upon exercise of outstanding warrants at a weighted average exercise price of $15.85 per share; |

| ● | 137,637 shares of common stock issuable upon exercise of outstanding options at a weighted average exercise price of $13.92 per share; and |

| ● | shares of common stock issuable upon the conversion of 76,480 shares of Series A Preferred Stock. |

<div align='center'>DESCRIPTION OF Capital Stock</div>

The following description of our capital stock is only a summary and is qualified in its entirety by reference to the actual terms and provisions of the capital stock contained in our Certificate of Incorporation and our Bylaws, copies of which are attached as exhibits to the registration statement of which this prospectus forms a part.

General

We are authorized to issue one class of stock.
The total number of shares of stock which we are authorized to issue is 151,000,000 shares of capital stock, 150,000,000 of which are
common stock, $0.0001 par value per share, and 1,000,000 of which are “blank check” Series A Preferred Stock. As of July 3,
2025, 1,472,891 shares of common stock were issued and outstanding and held by 21 stockholders of record.

Common Stock

The holders of our common stock are entitled to
the following rights:

Voting Rights. Each share of our
common stock entitles its holder to one vote per share on all matters to be voted or consented upon by the stockholders.

Dividend Rights. Subject to limitations
under Delaware law, holders of our common stock are entitled to receive ratably such dividends or other distributions, if any, as may
be declared by our Board out of funds legally available therefor.

Liquidation Rights. In the event
of liquidation, dissolution or winding up of our business, the holders of our common stock are entitled to share ratably in the assets
available for distribution after the payment of all of our debts and other liabilities.

Other Matters. The holders of our
common stock have no subscription, redemption or conversion privileges; in addition, such common stock does not entitle its holders to
pre-emptive rights. All of the outstanding shares of our common stock are fully paid and non-assessable.

Section 203 of the Delaware General Corporation Law

We are subject to the provisions of Section 203